1105 Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy. A French retrospective study of 13 cases

2013 ◽  
Vol 12 (1) ◽  
pp. e1105
Author(s):  
P. Bigot ◽  
J.C. Bernhard ◽  
E. Xylinas ◽  
T. Fardoun ◽  
J. Berger ◽  
...  
2013 ◽  
Vol 32 (1) ◽  
pp. 109-114 ◽  
Author(s):  
Pierre Bigot ◽  
Tarek Fardoun ◽  
Jean Christophe Bernhard ◽  
Evanguelos Xylinas ◽  
Julien Berger ◽  
...  

2006 ◽  
Vol 50 (2) ◽  
pp. 302-310 ◽  
Author(s):  
Jérôme Rigaud ◽  
Jean-François Hetet ◽  
Guillaume Braud ◽  
Simon Battisti ◽  
Loïc Le Normand ◽  
...  

2020 ◽  
Author(s):  
Xianwei Yang ◽  
Tao Wang ◽  
Junjie Kong ◽  
Bin Huang ◽  
Wentao Wang

Abstract Background: Retrohepatic inferior vena cava (RIVC) resection without reconstruction in ex vivo liver resection and autotransplantation (ERAT) for advanced alveolar echinococcosis (HAE) is unclear. Methods: This is a retrospective study of consecutive patients referred to our hospital from 2014 to 2018. Depending on the presence of a rich collateral circulation and stable blood volume in ERAT, patients did not rebuild the RIVC. Then, patients were selected some appropriate revascularization techniques for the hepatic and renal veins. Finally, all ERAT procedures were completed, and short- and long-term outcomes were observed. Results: Five advanced HAE patients underwent ERAT without RIVC reconstruction. One patient died of circulatory failure 1 day after surgery. Another four patients, with a median follow-up duration of 18 months (range, 10-25 months), demonstrated normal liver and kidney function, no thrombosis and no HAE recurrence. Conclusions: Through the long-term results of ERAT, the pros and cons of not reconstructing the RIVC need to be re-examined. In cases with a rich collateral circulation, the RIVC cannot be reconstructed. However, in cases requiring the resection of multiple organs, RIVC without reconstruction was prudential.


2021 ◽  
Author(s):  
Qi Zhang ◽  
Ming Li ◽  
Dongmei Fu ◽  
Dongxin Wang ◽  
Shiqi Diao

Abstract In patients with renal cell carcinoma (RCC) and cancer-related thrombosis in the inferior vena cava (IVC) or right atrium (AT), it is still unknown whether nephrectomy, anesthesia, and surgical trauma can cause postoperative acute kidney injury (AKI) and what are the risk factors for AKI. To examine the incidence and risk factors of postoperative AKI in patients who underwent unilateral radical nephrectomy and cardiopulmonary bypass (CPB)-assisted thrombectomy in the IVC and/or atrial AT due to RCC complicated with cancer-associated thrombosis. This retrospective study included patients who underwent unilateral radical nephrectomy and CPB-assisted thrombectomy in the inferior vena cava and/or atrial pulmonary artery due to RCC, under general anesthesia, from December 2011 to June 2015, at Peking University First Hospital. Among 31 patients, 15 (48.4%) had postoperative AKI. Compared with the non-AKI group (n = 16), patients in the AKI group (n = 15) were older (59.0 ± 8.7 vs. 48.5 ± 12.9 years, P = 0.012) had smaller intraoperative urine volume (1225 ± 639 vs. 1685 ± 597 mL, P = 0.048). There were no differences in preoperative creatinine clearance. Age (OR = 1.10, 95%CI: 1.02–1.20, P = 0.020) was independently associated with AKI occurrence. The patients undergoing unilateral radical nephrectomy and CPB-assisted IVC thrombectomy have a high rate of AKI. Older ones are at a higher risk of postoperative AKI.


Blood ◽  
2011 ◽  
Vol 118 (21) ◽  
pp. 3141-3141
Author(s):  
Erica A. Peterson ◽  
Paul R. Yenson ◽  
Dave Liu ◽  
Andy W.J. Lee ◽  
Agnes Y. Lee

Abstract Abstract 3141 Background: Inferior vena cava filter (IVCF) use has been rising exponentially since the introduction of percutaneous image guided IVCF placement and the subsequent development of optional recovery models. Optional recovery IVCFs are preferred over permanent devices as an alternative or adjunct to anticoagulation to prevent pulmonary embolism (PE) in patients with venous thromboembolism (VTE) due to their ability to be retrieved once they are no longer needed. In 2010, the US Food and Drug Administration issued a safety alert for optional recovery filters following reports of adverse events associated with their widespread use. Attempted removal rates reported in the literature are suboptimal, ranging from 15 to 70% in single centre studies. We conducted a retrospective study to determine IVCF complications, retrieval rates and barriers to removal in our institution. Methods: Consecutive patients who had a retrievable IVCF inserted or removed by the Interventional Radiology department from January 1st 2007 to June 30th 2010 were identified from a prospective database. Data were extracted from chart review using standardized forms. Outcomes collected included indication for IVCF, frequency of removal, documentation of an IVCF plan (for retrieval or not), reasons for non-retrieval, and all-cause mortality. A bivariate comparison of patients who had an attempted IVCF retrieval or not was performed. Patient characteristics were compared using 2-sided t-tests for continuous variables and chi-square analysis for categorical variables. Multivariate analysis by binary logistic regression was performed for significant variables (p<0.20) on univariate analysis. All statistics were performed using SPSS software. Results: 242 patients were identified with a median age of 60 years (range 14–93 y) of which 52.9% were male. Underlying thrombotic conditions included: acute (<3 months) VTE (76.9%), malignancy (35.1%) and trauma (21.5%). Indications for IVCF placement were acute (63.6%) or prior (8.3%) VTE with contraindication to anticoagulation, high risk of PE (14.5%) and primary prophylaxis (13.6%). A total of 37 patients died at a median of 13 d (range 1–66 d) after IVCF insertion. Retrieval was attempted in 58.1% (140/242 patients) and was successful in 89.9% (124 patients). The most common reason for failed retrieval attempt was filter thrombus (N=12). In the 33 patients with filter placement for primary prophylaxis 20 (60.6%) had a removal attempt with a success rate of 100%. Reasons for IVCF non-retrieval (102 patients) included death or limited life expectancy (N=39, 38.2%), plan to make the filter permanent (N=17, 16.7%), persistent/permanent contraindication to anticoagulation (N=14, 13.7%), persistent high risk of PE despite anticoagulation (N=2, 2%), planned indefinite anticoagulation (N=1, 0.98%), transfer to another province (N=2, 2%) and unknown/unspecified in chart (N=27, 26.5%). Predictors of attempted retrieval on multivariate analysis included documentation of filter plan (p<0.001) and age <70 years (p=0.016). In 27 patients (11.1%), removal was not attempted despite a lack of indication for IVCF to remain in situ; of these, 16 patients had no documented retrieval plan. Patients with no identifiable reason for non-retrieval were more likely to be cancer-free (p=0.010), admitted under a surgical service (p=0.009) and not have a consulting hematologist's involvement (p=0.041). Conclusion: Our single-centre IVC filter recovery rate compares favorably to published reports but remains suboptimal. Failure to document a filter plan and age > 70 years were the only predictors of a lower rate of attempted IVC filter recovery. A significant proportion of patients (11.1%) who did not undergo an attempted IVC filter recovery had no identifiable reason not to do so. Improper documentation may play a significant role in failure to recover devices, particularly in patients with no contraindications to removal. Further studies are needed to identify barriers to retrieval and improve removal rates. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document